Phreesia, Inc. (NYSE:PHR) General Counsel Sells $180,158.88 in Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman sold 6,556 shares of the business’s stock in a transaction on Monday, January 27th. The shares were sold at an average price of $27.48, for a total transaction of $180,158.88. Following the transaction, the general counsel now owns 152,361 shares of the company’s stock, valued at $4,186,880.28. This trade represents a 4.13 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Phreesia Stock Performance

Phreesia stock opened at $29.03 on Friday. The firm has a fifty day simple moving average of $24.78 and a two-hundred day simple moving average of $23.24. Phreesia, Inc. has a twelve month low of $17.07 and a twelve month high of $29.90. The company has a market capitalization of $1.69 billion, a PE ratio of -19.75 and a beta of 0.94. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04.

Phreesia (NYSE:PHR) last issued its earnings results on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company had revenue of $106.80 million during the quarter, compared to analysts’ expectations of $106.33 million. During the same period in the prior year, the business posted ($0.58) EPS. Phreesia’s quarterly revenue was up 16.6% compared to the same quarter last year. Research analysts expect that Phreesia, Inc. will post -1.1 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in PHR. R Squared Ltd bought a new stake in Phreesia during the 4th quarter valued at $30,000. International Assets Investment Management LLC increased its position in shares of Phreesia by 2,179.7% in the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock valued at $33,000 after acquiring an additional 1,395 shares during the period. XTX Topco Ltd bought a new position in shares of Phreesia during the third quarter valued at about $247,000. Hsbc Holdings PLC purchased a new stake in shares of Phreesia during the second quarter worth about $301,000. Finally, Intech Investment Management LLC bought a new stake in shares of Phreesia in the third quarter worth about $316,000. Institutional investors own 92.10% of the company’s stock.

Wall Street Analyst Weigh In

PHR has been the subject of several recent analyst reports. Truist Financial boosted their target price on Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. JMP Securities reissued a “market outperform” rating and set a $30.00 price objective on shares of Phreesia in a report on Tuesday, December 10th. Citigroup upped their price objective on shares of Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a research report on Friday, January 10th. Needham & Company LLC reiterated a “buy” rating and set a $29.00 target price on shares of Phreesia in a research report on Friday, January 10th. Finally, Robert W. Baird decreased their price target on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating on the stock in a report on Wednesday, December 11th. Thirteen research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $31.15.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.